The FDA released a discussion paper and request for feedback on possible regulatory approaches for generative AI-enabled medical devices. The agency is seeking public input on how existing medical device oversight may apply as generative AI features are incorporated into healthcare technologies. This is a notable healthcare law and policy development because it signals active federal consideration of how safety, effectiveness, and post-market oversight should work for AI-enabled devices.
